Promises and challenges of biologics for severe asthma

10.1016/j.bcp.2020.114012

Saved in:

Bibliographic Details
Main Authors:	Tan, Ronnie, Liew, Mei Fong, Lim, Hui Fang, Leung, Bernard P, Wong, WS Fred
Other Authors:	PHARMACOLOGY
Format:	Review
Language:	English
Published:	PERGAMON-ELSEVIER SCIENCE LTD 2023
Subjects:	Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy Omalizumab Mepolizumab Dupilumab Thymic stromal lymphopoietin IL-33 SEVERE EOSINOPHILIC ASTHMA SEVERE ALLERGIC-ASTHMA UNCONTROLLED PERSISTENT ASTHMA INNATE LYMPHOID-CELLS ADD-ON THERAPY DOUBLE-BLIND AIRWAY INFLAMMATION MONOCLONAL-ANTIBODY INHALED CORTICOSTEROIDS OMALIZUMAB
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/239309
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore
Language:	English

id	sg-nus-scholar.10635-239309
record_format	dspace
spelling	sg-nus-scholar.10635-2393092024-11-15T16:12:46Z Promises and challenges of biologics for severe asthma Tan, Ronnie Liew, Mei Fong Lim, Hui Fang Leung, Bernard P Wong, WS Fred PHARMACOLOGY MEDICINE PHYSIOLOGY MICROBIOLOGY AND IMMUNOLOGY Prof Wai-Shiu Fred Wong Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy Omalizumab Mepolizumab Dupilumab Thymic stromal lymphopoietin IL-33 SEVERE EOSINOPHILIC ASTHMA SEVERE ALLERGIC-ASTHMA UNCONTROLLED PERSISTENT ASTHMA INNATE LYMPHOID-CELLS ADD-ON THERAPY DOUBLE-BLIND AIRWAY INFLAMMATION MONOCLONAL-ANTIBODY INHALED CORTICOSTEROIDS OMALIZUMAB 10.1016/j.bcp.2020.114012 BIOCHEMICAL PHARMACOLOGY 179 2023-05-11T07:48:10Z 2023-05-11T07:48:10Z 2020-09-01 2023-05-11T05:45:11Z Review Tan, Ronnie, Liew, Mei Fong, Lim, Hui Fang, Leung, Bernard P, Wong, WS Fred (2020-09-01). Promises and challenges of biologics for severe asthma. BIOCHEMICAL PHARMACOLOGY 179. ScholarBank@NUS Repository. https://doi.org/10.1016/j.bcp.2020.114012 0006-2952 1873-2968 https://scholarbank.nus.edu.sg/handle/10635/239309 en PERGAMON-ELSEVIER SCIENCE LTD Elements
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
language	English
topic	Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy Omalizumab Mepolizumab Dupilumab Thymic stromal lymphopoietin IL-33 SEVERE EOSINOPHILIC ASTHMA SEVERE ALLERGIC-ASTHMA UNCONTROLLED PERSISTENT ASTHMA INNATE LYMPHOID-CELLS ADD-ON THERAPY DOUBLE-BLIND AIRWAY INFLAMMATION MONOCLONAL-ANTIBODY INHALED CORTICOSTEROIDS OMALIZUMAB
spellingShingle	Science & Technology Life Sciences & Biomedicine Pharmacology & Pharmacy Omalizumab Mepolizumab Dupilumab Thymic stromal lymphopoietin IL-33 SEVERE EOSINOPHILIC ASTHMA SEVERE ALLERGIC-ASTHMA UNCONTROLLED PERSISTENT ASTHMA INNATE LYMPHOID-CELLS ADD-ON THERAPY DOUBLE-BLIND AIRWAY INFLAMMATION MONOCLONAL-ANTIBODY INHALED CORTICOSTEROIDS OMALIZUMAB Tan, Ronnie Liew, Mei Fong Lim, Hui Fang Leung, Bernard P Wong, WS Fred Promises and challenges of biologics for severe asthma
description	10.1016/j.bcp.2020.114012
author2	PHARMACOLOGY
author_facet	PHARMACOLOGY Tan, Ronnie Liew, Mei Fong Lim, Hui Fang Leung, Bernard P Wong, WS Fred
format	Review
author	Tan, Ronnie Liew, Mei Fong Lim, Hui Fang Leung, Bernard P Wong, WS Fred
author_sort	Tan, Ronnie
title	Promises and challenges of biologics for severe asthma
title_short	Promises and challenges of biologics for severe asthma
title_full	Promises and challenges of biologics for severe asthma
title_fullStr	Promises and challenges of biologics for severe asthma
title_full_unstemmed	Promises and challenges of biologics for severe asthma
title_sort	promises and challenges of biologics for severe asthma
publisher	PERGAMON-ELSEVIER SCIENCE LTD
publishDate	2023
url	https://scholarbank.nus.edu.sg/handle/10635/239309
_version_	1821216866805219328

Promises and challenges of biologics for severe asthma

Similar Items